The Guardian is running a major editorial series called The Pain That Can’t be Seen, which takes an in-depth look at the growing health issue of chronic pain and how the pandemic might have exacerbated it given musculoskeletal pain is a common complaint of those who have had Covid-19.
“Sufferers of chronic pain have long been told it’s all in their head. We now know that’s not true. This series looks at why doctors are playing catch-up on chronic pain conditions like endometriosis, migraine and more â€“ and what they have to do with long Covid.”
From Nikki Marshall’s ongoing battle with Fibromyalgia, to harrowing personal tales of readers who are dealing with the impacts of long Covid, to a video explainer on how nociplastic pain works, the series offers an excellent summary of a disability that is currently thought to affect one in five people around the world and is expected to rise as the population ages.
Exsurgo’s recent proof-of-concept trial in the UK showed that patients using the proprietary Axon system reported significant reductions in their levels of pain, anxiety and depression. At the same time, they reported improvements in sleep, mood and quality of life. Read more about the results here.